|
|||||
|
|
Oral Anticoagulation and Cardiovascular Outcomes in Patients With Atrial Fibrillation and End-Stage Renal Disease |
|
| Institution: | 1. Duke Center for Atrial Fibrillation, Duke University Medical Center, Durham, North Carolina;2. Duke Clinical Research Institute, Durham, North Carolina;3. Division of Electrophysiology, Yale School of Medicine, New Haven, Connecticut |
| Abstract: | |
| Keywords: | anticoagulation atrial fibrillation bleeding end-stage renal disease stroke AF"} {"#name":"keyword" "$":{"id":"kwrd0040"} "$$":[{"#name":"text" "_":"atrial fibrillation ESRD"} {"#name":"keyword" "$":{"id":"kwrd0050"} "$$":[{"#name":"text" "_":"end-stage renal disease OAC"} {"#name":"keyword" "$":{"id":"kwrd0060"} "$$":[{"#name":"text" "_":"oral anticoagulant |
| 本文献已被 ScienceDirect 等数据库收录！ | |